Patients from Basingstoke contribute to the PRECISION Study for Prostate Cancer Diagnosis
15 Mar 2018
Great steps forward this week as the results of the PRECISION Study were published in the New England Journal of Medicine. The PRECISION Study has looked at mpMRI vs TRUS biopsy for prostate cancer diagnosis.
Urology Partners have been using mpMRI scanning as part of our prostate cancer diagnosis for five years and it was a privilege to work with colleagues on this study and get the results which will change the pathway for prostate cancer diagnosis.
Richard Hindley commented "I am so proud that Basingstoke has been able to contribute to such an International collaboration - the results published in the New England Journal of Medicine have confirmed that a targeted biopsy approach, using mpMRI scanning, in prostate cancer detection leads to better results."
"The ideal test for prostate cancer would be minimally invasive, have few side effects, identify a high proportion of men who would benefit from treatment and minimize the identification of men with clinically insignificant cancer in order to prevent overtreatment".
"PRECISION has demonstrated this and furthermore, nearly 1/3 of men will avoid unnecessary biopsy.”
Read the full article in the NEJM here
Urology Partners win Private Healthcare Award for Innovation and Patient Care
08 Mar 2018
We are delighted and proud to announce that we have been awarded 2 awards in the Global Health and Pharma Private Healthcare Awards 2018.
Urology Partners have been awarded Most Innovative Private Urology Practice - Excellence Award for Urology Patient Care 2018
This follows a year of great progress for the Prostate Cancer diagnosis pathway with the PROMIS trials results which our consultants were involved in and recruited patients to the study.
In addition Richard Hindley and Neil Barber have been leading the way with new treatments for BPH with the arrival of Rezum and the continuing trials for Aquablation.
We look forward to another year of continuing progress enabling us to ensure our patients have the opportunity to choose the best treatment to suit them and the care and experience our team provide.
Next Steps for Aquablation
09 Jan 2018Christmas brought good news for Aquablation as the FDA approved a De Novo request for the AquaBeam system. Neil Barber has been part of the Open WATER trial here in the UK in this game changing treatment for BPH.
Urolift success in the NHS
14 Dec 2017As the popularity of the Urolift procedure sees it being increasingly used to treat BPH symptoms across the NHS, BBC Radio Hereford & Worcester report on the use in it's local hospital. As the leading surgeon for Urolift in the UK, Neil Barber talked to the breakfast show about the impact on patients and the success of the procedure.
Aquablation - a patient and surgeon view
30 Nov 2017
Aquablation is new emerging technology for treating Lower Urinary Tract symptoms associated with BPH. Neil Barber hs been trialling this new minimally invasive procedure and The Daily Mail brings the story from the patient view on what was a problematic chain of events and symptoms which have been treated successfully, enabling the patient to resume his normal life within 3 days.
Making Movember Massive
02 Nov 2017Movember and moustaches have been together since 2003 and the impact on Men's Health has been monumental.
Most importantly, getting men to speak out about their health and raise awareness on sensitive subjects has been enlightening. Crucially Movember unites men across the globe and sharing stories and fundraising can only have a positive impact.
Research continues all the time and Movember is our chance to shout out about it.
In the world of Urology, 2017 saw a big step forward in the prostate cancer diagnosis pathway. The results of the PROMIS trial highlighted the critical success of using mpMRI scanning before biopsy in men suspected with prostate cancer. It's a total game changer in the precision diagnostics and a method that all our consultants at Urology Partners have been using for over 3 years for our patients. We need patients to know that they are all entitled to it. Read more on ensuring you get the most accurate diagnostic in this Daily Mail article
However, the subject of men's prostates is not limited to prostate cancer.
The statistics speak for themselves here and show just how many men are affected by prostate related problems. BUT it's not a subject every man wants to talk about.
Finding out more... Prostate Cancer Diagnosis Pathway
24 Oct 2017If you've just seen your consultant Urologist and been recommended to have a mpMRI scan for possible prostate cancer, chances are you're feeling worried, concerned and also have a heap of questions running through your mind.
Travelling miles for Urolift
11 Oct 2017This patient, living in Cornwall, travelled to Surrey to see Neil Barber and have the Urolift procedure.
Don't let treating an enlarged prostate ruin your sex life
20 Sep 2017
Richard offers this treatment privately at BMI The Hampshire Clinic and The Candover Clinic at North Hampshire Hospital.
To make an appointment with Richard, visit our contact page
Richard Hindley brings Rezum treatment to the UK in Hampshire and Surrey
25 Jul 2017
Richard Hindley carried out his first Rezum treatment for BPH back in March and now following 3 month results, one patient tells his story to The Daily Mail.
Richard has now carried out 20 cases both on the NHS at North Hampshire Hospital and privately at BMI The Hampshire Clinic.
In addition, Neil Barber has carried out the procedure from their London practice at Nuada, 19 Harley Street.
The new minimally invasive treatment for BPH is so far showing good 3 month results. The procedure is already FDA approved in the US and they are treating around 1,000 patients a month with this procedure.
The advantages of a short time in hospital, allowing for a speedy recovery and back to normal routines make it an exciting new option for patients and hospitals alike.
You can also read more on our treatments section
Our four consultants at Urology Partners are all able to offer this treatment privately.